Project Grant HT94252310516
Award Date
6/15/23
Completion Date
6/14/26
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $766,965 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on June 30, 2024. The grant supports a 3-year research project to develop new methods for targeting kidney cancer tumors in order to improve immunotherapy outcomes. The research aims to identify tumor surface biomarkers that can be leveraged to enhance the effectiveness of cancer...
The University of Texas Southwestern Medical Center (UT Southwestern) has been awarded a Project Grant for $1,180,962.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 30, 2024, will support a research project titled "TUMOR SURFACE BIOMARKER-INDEPENDENT TARGETING OF KIDNEY CANCER TO IMPROVE IMMUNOTHERAPY" over a performance period ending on June 29, 2027. The grant funding will enable UT...
This $1,189,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to target stem-like CD8 T cells in immunotherapy against kidney cancer. The grant was awarded on September 1, 2023 to The University of Texas Southwestern Medical Center, an academic medical institution and component of the University of Texas System, to be completed by August 31, 2027. Through this funding, UT Southwestern will conduct research...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,083,136 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from August 15, 2023 through August 14, 2026 to leverage SCARB1 overexpression for the treatment of clear cell renal cell carcinoma (CCRCC) using low-density lipoprotein nanocarriers. UT Southwestern has extensive experience delivering...
The Defense Health Agency awarded a $1,107,001 Project Grant to The University of Texas Southwestern Medical Center (UT Southwestern) to conduct research on the DROSHA gene's role in regulating mesenchymal expression and chemosensitivity in Wilms tumor. The grant was awarded on September 30, 2023 and will run through September 29, 2026 under the Military Medical Research and Development program (CFDA 12.420). UT Southwestern, a component of the University of Texas System, will lead the...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $713,689 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, effective September 1, 2023, will support UT Southwestern's research to leverage biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. The grant provides funding for basic...
This Project Grant award of $1,106,902.00 was provided by the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award supports research at the University of Texas Southwestern Medical Center in Dallas, Texas to "delineate tumor-immune contexture that shapes clear cell renal cell carcinoma (ccRCC) metastatic progression and response to immunotherapy." The 3-year project aims to advance the understanding of the tumor-immune...
The University of Texas Southwestern Medical Center was awarded a $1,467,321 project grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research from August 1, 2023 to July 31, 2026 to investigate the mechanisms controlling the progression of prostate adenocarcinoma to neuroendocrine cancer. As part of its mission to transform military and public health through innovative medical research solutions, the Defense Health Agency...
The Defense Health Agency awarded a $492,927 Project Grant to The University of Texas Southwestern Medical Center in Dallas, Texas to conduct research on leveraging biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. This 3-year grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health...
The University of Texas Southwestern Medical Center was awarded a $984,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Ribosome Marylation and Stress Responses in Ovarian Cancer: New Therapeutic Opportunities". The 3-year grant, effective September 1, 2024, will support basic science, translational, and clinical research to investigate new treatment approaches for ovarian cancer. As a...